Istituto Superiore di Sanità-ko ikertzaileekin lankidetzan egindako argitalpenak (13)

2022

  1. Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study

    Journal of Cystic Fibrosis, Vol. 21, Núm. 4, pp. e221-e231

  2. Geographic distribution and phenotype of European people with cystic fibrosis carrying A1006E mutation

    Respiratory Medicine, Vol. 192

2021

  1. Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: An international observational study

    Journal of Cystic Fibrosis, Vol. 20, Núm. 1, pp. 25-30

  2. How donor selection criteria can be evaluated with limited scientific evidence: lessons learned from the TRANSPOSE project

    Vox Sanguinis, Vol. 116, Núm. 3, pp. 342-350

  3. Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020

    Journal of Cystic Fibrosis, Vol. 20, Núm. 4, pp. 566-577

2020

  1. Primrose syndrome: Characterization of the phenotype in 42 patients

    Clinical Genetics, Vol. 97, Núm. 6, pp. 890-901

  2. The global impact of SARS-CoV-2 in 181 people with cystic fibrosis

    Journal of Cystic Fibrosis, Vol. 19, Núm. 6, pp. 868-871

2018

  1. Joint data analysis in nutritional epidemiology: Identification of observational studies and minimal requirements

    Journal of Nutrition, Vol. 148, Núm. 2, pp. 285-297

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

  3. Social/economic costs and health-related quality of life in patients with histiocytosis in Europe

    European Journal of Health Economics, Vol. 17, pp. 67-78

2011

  1. High fat diet-induced non alcoholic fatty liver disease in rats is associated with hyperhomocysteinemia caused by down regulation of the transsulphuration pathway

    Lipids in Health and Disease, Vol. 10

2009

  1. Hepatic VLDL assembly is disturbed in a rat model of nonalcoholic fatty liver disease: Is there a role for dietary coenzyme Q?

    Journal of Applied Physiology, Vol. 107, Núm. 3, pp. 707-717